Total Voting Rights
London, UK, 02 February 2010: Lombard Medical (AIM: LMT), the specialist medical device company, announces that following the admission to AIM this morning of the 1,333,390,207 shares issued pursuant to the placing, subscription and offer the Company has an issued share capital of 2,174,694,973 ordinary shares with a nominal value of 1 pence each, with voting rights.
Lombard Medical does not hold any ordinary shares in Treasury. Therefore, the total number of voting rights in Lombard Medical is 2,174,694,973.
The above figure of 2,174,694,973 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Lombard Medical under the Financial Service Authority's Disclosure and Transparency Rules.
- Ends -
Enquiries:
Lombard Medical Technologies PLC
Tel: +44 (0) 1235 750 800
Simon Neathercoat, Non-executive Chairman
John Barry Rush, Chief Executive Officer
Tim Hall, Finance Director
Evolution Securities Limited
Barry Saint
Tim Redfern
Esther Lee Tel: +44 (0) 20 7071 4300
Financial Dynamics Tel: +44 (0) 20 7831 3113
Jonathan Birt
Susan Quigley
Notes to editors
Lombard Medical Technologies PLC is a medical devices group developing stent grafts and other medical products for use in the treatment of vascular disease. The Company’s lead product, Aorfix™, is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAAs), a balloon-like enlargement of the aorta which, if untreated, may rupture and cause death.
Approximately 4.5 million people are living with AAA in the developed world and each year 600,000 new cases are diagnosed. The market for endovascular stent grafts for the treatment of AAA is currently worth approximately $900 million and is expected to grow to around $1.6 billion by 2015. Aorfix™ has CE Mark approval in the EU and is currently being commercialised in the EU, with a pivotal clinical trial ongoing in the USA.
The Company is headquartered in Oxfordshire, with operations in Prestwick, Ayrshire and Boston, USA.
Further background on the Company can be found at www.lombardmedical.com.